Edmund Dunn
Principal Accounting Officer at Monte Rosa Therapeutics, Inc. (GLUE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $483K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 5SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell | 13922,554 held (−1%) | $17.96 | $2K | -45.8% |
| Mar 2SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell | 25,16422,693 held (−53%) | $18.10 | $455K | -46.2% |
| Mar 2SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell | 53622,693 held (−2%) | $17.50 | $9K | -44.3% |
| Jan 5SEC | GLUEMonte Rosa Therapeutics, Inc. | Sell | 1,03922,693 held (−4%) | $15.17 | $16K | -35.8% |
- Sell
Principal Accounting Officer Edmund Dunn sold $455K of GLUE at $18.10 — cuts the stake by 53%.